Alerts will be sent to your verified email
Verify EmailBIBCL
|
Bharat Immunological
|
Makers Laboratories
|
Vivimed Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 3.8 % | 184.61 % |
|
5yr average Equity Multiplier
|
3.08 | 2.36 | -33.72 |
|
5yr Average Asset Turnover Ratio
|
0.61 | 0.7 | 0.27 |
|
5yr Avg Net Profit Margin
|
-18.38 % | -0.21 % | -54.08 % |
|
Price to Book
|
0.95 | 1.33 | 0.0 |
|
P/E
|
0.0 | 77.28 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
206.63 Days | 75.08 Days | 184.52 Days |
|
Inventory Days
|
125.06 Days | 107.1 Days | 244.76 Days |
|
Days Receivable
|
61.4 Days | 71.83 Days | 246.32 Days |
|
Days Payable
|
117.81 Days | 106.28 Days | 159.64 Days |
|
5yr Average Interest Coverage Ratio
|
-2.32 | 4.73 | -6.61 |
|
5yr Avg ROCE
|
-44.64 % | 6.35 % | -13.87 % |
|
5yr Avg Operating Profit Margin
|
-18.7 % | 7.59 % | -26.56 % |
|
5 yr average Debt to Equity
|
0.71 | 0.21 | -13.68 |
|
5yr CAGR Net Profit
|
23.51 % | n/a | -14.97 % |
|
5yr Average Return on Assets
|
-10.1 % | 0.25 % | -10.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.25 % | 61.27 % | 7.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 15.18 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -13.37 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Immunological
|
Makers Laboratories
|
Vivimed Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|